We provide two services: OncoAct and Hartwig Sequencing Services.
Cancer is caused by DNA mutations. To find these mutations, we developed OncoAct. OncoAct is a complete DNA test that can provide physicians with additional information about clinically relevant characteristics of a tumor (biomarkers) that may also be predictive of the response to treatment.
Changes in the genetic profile (mutations) sometimes provide clues to a potential treatment that can directly target these mutations. This is known as targeted therapy.
In addition, the OncoAct report contains possible leads for trials or experimental drugs.
We sequence and analyze DNA for research purposes.
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so important that comprehensive patient reports include precisely that carrier information, if the patient wishes to be informed of it.